跳至主要内容
临床试验/NCT02618057
NCT02618057Unknown4 期

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia With Lobar Consolidation or Pleural Effusion in Children

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
Fever duration

研究概览

简要总结

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children.

详细描述

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children. Participants will be randomly assigned (1:1 ratio) to receive either prednisone 1 mg/kg/d daily for 5 days or none. The primary endpoint was fever duration and analysed by intention to treat.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Evidence of Mycoplasma pneumoniae infection
  • Lobar pneumonia or pneumoniae with pleural effusion

排除标准

  • Immunosuppresant host
  • Chronic cardiovascular/pulmonary disease
  • Hospital acquired infection

研究组 & 干预措施

Steroid

Experimental

Prednisolone, 1.0 mg/kg/day, PO, for 5 days Levofloxacin, 10mg/kg/day, IV, for 5days

干预措施: Prednisolone (Drug)

Steroid

Experimental

Prednisolone, 1.0 mg/kg/day, PO, for 5 days Levofloxacin, 10mg/kg/day, IV, for 5days

干预措施: Levofloxacin (Drug)

Control

Active Comparator

Levofloxacin, 10mg/kg/day, IV, for 5days

干预措施: Levofloxacin (Drug)

结局指标

主要结局

Fever duration

时间窗: within the first 14 days after intervention

次要结局

  • Number of patients improved in chest X-ray(within the first 14 days after intervention)
  • Number of patients with side effect of steroid(within the first 14 days after intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验